Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 2431 AL 2445

A hypothesis explaining Alzheimer's disease, Parkinson's disease, and dementia with Lewy bodies overlap

Lau VZ, Awogbindin IO, Frenkel D, Whitehead SN, Tremblay MÈ.

Alzheimers Dement. 2025 Jun;21(6):e70363. doi: 10.1002/alz.70363.

Pick's disease presenting as progressive apraxia of speech: Atypical clinical and neuroimaging features in three autopsy-confirmed cases

Jones KE, Graff-Radford J, Utianski RL, Duffy JR, Clark HM, Machulda MM, Dickson DW, Whitwell JL, Josephs KA, Botha H.

Clin Neurol Neurosurg. 2025 Sep;256:109018. doi: 10.1016/j.clineuro.2025.109018. Epub 2025 Jun 18.

The cognitive and neurological implications of toxoplasma gondii infection: Evidence from a systematic review and meta-analysis

Kavakebian M, Ghandali T, Nasiri H, Ramezani-Moghadam F, Alizadeh S, Alizadeh S, Silakhor M, Rajabi M, Mirmazhari A, Asgarian P, Rahimi H, Karimi M, Moosazadeh M.

Acta Trop. 2025 Aug;268:107705. doi: 10.1016/j.actatropica.2025.107705. Epub 2025 Jun 21.

Advancing Amyloid Aggregation Research: A Focus on Innovative Therapies, Molecular Modeling and Nano-Delivery Systems in Alzheimer's Disease

Hasan U, Jain H, Ali R.

Curr Drug Targets. 2025;26(11):779-798. doi: 10.2174/0113894501388678250618070927.

Targeting the redox neuroinflammatory nexus: insights into Alzheimer's and Parkinson's diseases

Dharshini LCP, Sakthivel KM, Rex KGR, Rasmi RR.

Inflammopharmacology. 2025 Jul;33(7):3885-3895. doi: 10.1007/s10787-025-01831-w. Epub 2025 Jul 2.

The prevalence of apathy in Lewy body dementia: A systematic review and meta-analysis

Yu JJ, Chin KS, Loveland PM, Churilov L, Loi SM, Yassi N, Watson R.

Alzheimers Dement. 2025 Jul;21(7):e70425. doi: 10.1002/alz.70425.

Detoxification and age-related neurodegenerative diseases: Correlation and therapeutic potential

Yan Y, Maisenbacher M, Huang C, Fan S.

Pharmacol Res. 2025 Aug;218:107849. doi: 10.1016/j.phrs.2025.107849. Epub 2025 Jul 2.

Neuroprotective effects of essential oils in animal models of Alzheimer's and Parkinson's disease: a systematic review

Macedo ADES, Ferreira TM, Krejcová LV, Rocha FAF, da Silva JKR, Pedrosa LRR, Gomes BD.

PeerJ. 2025 Jul 10;13:e19643. doi: 10.7717/peerj.19643. eCollection 2025.

Efficacy of repetitive transcranial magnetic stimulation in cognitive impairment of neurodegenerative diseases: a systematic review and meta-analysis

Zhang Y, Xu K, Wang Y, Shen Y, Liu Z, Zhang C, Zhou Y, Lv P, Bai Y, Wang S.

BMC Neurol. 2025 Jul 17;25(1):295. doi: 10.1186/s12883-025-04292-4.

Next-generation CRISPR gene editing tools in the precision treatment of Alzheimer's and Parkinson's disease

Meshram HK, Gupta SK, Gupta A, Nagori K, Ajazuddin.

Ageing Res Rev. 2025 Sep;111:102851. doi: 10.1016/j.arr.2025.102851. Epub 2025 Aug 5.

Searching Heterocyclic Scaffolds Used to Treat Alzheimer's Disease: A Review

Kale MA, Faisal M.

Curr Drug Res Rev. 2025;17(2):266-281. doi: 10.2174/0125899775290026240612104933.

The link between oral health and neurodegeneration: a review of periodontitis in Alzheimer's and Parkinson's disease and dementia

Wagaskar P, Gaikwad S, Suryawanshi M, Patil A.

Inflammopharmacology. 2025 Sep;33(9):5023-5036. doi: 10.1007/s10787-025-01888-7. Epub 2025 Aug 12.

An Interdisciplinary Approach to Assistive Technology for Parkinson's Disease Dementia

Munzesheimer S, Siu TWT, Yacinthe D, Garcia-Casals M, Haq IU, Shpiner DS.

Clin Interv Aging. 2025 Aug 15;20:1253-1265. doi: 10.2147/CIA.S516786. eCollection 2025.

Converging pathologies in neurodegeneration: the mechanistic interplay between α-Synuclein and Tau in Alzheimer's and Parkinson's

Jeyabalan JB, Pandi A V, Veintramuthu S, Sivasamy R, Dhanasekaran M, Justin A.

Neurol Sci. 2025 Oct;46(10):4779-4789. doi: 10.1007/s10072-025-08421-2. Epub 2025 Aug 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias